Investors are scrutinizing the prospects for some drugs in the pipeline following a string of recent rejections from the U.S. Food and Drug Administration.

TD Cowen 46th Annual Health Care Conference March 3, 2026 9:50 AM ESTCompany ParticipantsRamy Farid - CEO, President ...

Lisa Ashe, and expert in math education, says North Carolina is on the right track to improve students' math scores.

Reimagining their offense and making it a reality is a central theme of spring training as the Rockies try to rebound from a ...

Xanadu Quantum Technologies Inc. ("Xanadu"), a leading photonic quantum computing company, announced today that it has been selected to receive $2,027,507 in funding from the U.S. Department of Energy ...

He and the other two hundred and ten passengers on Singapore Airlines Flight SQ321 had been in the air for more than ten hours. Their flight had taken off the night before from the United Kingdom, ...

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

This study presents valuable findings for identifying biotypes of depression patients using white matter measures, which are under-utilised and under-appreciated in current biological and ...

Martinrea International (TSE:MRE) executives highlighted record free cash flow, improving margins, and continued cost recovery efforts tied to tariffs and electric-vehicle (EV) volume shortfalls ...

Venus and Saturn are due up for a visually striking event known as a planetary conjunction. Here's everything to know about ...

We released our results and are hosting today's call to discuss Riskified Ltd.'s financial results for the fourth quarter and ...

RASolute 302 Phase 3 catalyst, cash runway, and valuation risks for daraxonrasib. Read more macro analysis here.